CR9930A - Compuestos - Google Patents

Compuestos

Info

Publication number: CR9930A
Authority: CR; Costa Rica
Prior art keywords: compounds; antibacterials; compounds containing; containing tricyclic; tricyclic nitrogen
Prior art date: 2005-10-21

Application number

CR9930A

Other languages

English (en)

Spanish (es)

Inventor

Nathalie Cailleau

David Thomas Davies

Joel Michael Esken

Alan Joseph Hennessy

Sukumar Senthil Kumar Kusalakumari

Roger Edward Markwell

Timothy James Miles

Neil David Pearson

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-21

Filing date

2008-04-25

Publication date

2008-07-29

2008-04-25 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2008-07-29 Publication of CR9930A publication Critical patent/CR9930A/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

CR9930A 2005-10-21 2008-04-25 Compuestos CR9930A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US72897505P	2005-10-21	2005-10-21
US82659006P	2006-09-22	2006-09-22

Publications (1)

Publication Number	Publication Date
CR9930A true CR9930A (es)	2008-07-29

Family

ID=38256822

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CR9930A CR9930A (es)	2005-10-21	2008-04-25	Compuestos

Country Status (27)

Country	Link
US (2)	US20080221110A1 (fr)
EP (1)	EP1954697B1 (fr)
JP (1)	JP2009512695A (fr)
KR (1)	KR20080064173A (fr)
AR (1)	AR057981A1 (fr)
AT (1)	ATE458737T1 (fr)
AU (1)	AU2006335042A1 (fr)
BR (1)	BRPI0617467A2 (fr)
CA (1)	CA2626641A1 (fr)
CR (1)	CR9930A (fr)
CY (1)	CY1110137T1 (fr)
DE (1)	DE602006012535D1 (fr)
DK (1)	DK1954697T3 (fr)
EA (1)	EA200801128A1 (fr)
ES (1)	ES2340531T3 (fr)
HK (1)	HK1118546A1 (fr)
HR (1)	HRP20100194T8 (fr)
IL (1)	IL190803A0 (fr)
MA (1)	MA29873B1 (fr)
NO (1)	NO20082191L (fr)
NZ (1)	NZ567315A (fr)
PE (1)	PE20070793A1 (fr)
PL (1)	PL1954697T3 (fr)
PT (1)	PT1954697E (fr)
SI (1)	SI1954697T1 (fr)
TW (1)	TW200736263A (fr)
WO (1)	WO2007081597A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1954697T3 (da) *	2005-10-21	2010-06-14	Glaxo Group Ltd	Peri-kondenserede tricykliske forbindelser, der er anvendelige som antibakterielle midler
EP1963324B1 (fr) *	2005-12-22	2010-04-21	Glaxo Group Limited	Composes heterocycliques, leur synthese et leur utilisation en tant qu'antibacteriens
ATE481406T1 (de)	2006-04-06	2010-10-15	Glaxo Group Ltd	Pyrrolochinoxalinonderivate als antibakterielle mittel
GB0608263D0 (en)	2006-04-26	2006-06-07	Glaxo Group Ltd	Compounds
GB0613208D0 (en) *	2006-07-03	2006-08-09	Glaxo Group Ltd	Compounds
GB0705672D0 (en) *	2007-03-23	2007-05-02	Glaxo Group Ltd	Compounds
CL2008001002A1 (es)	2007-04-11	2008-10-17	Actelion Pharmaceuticals Ltd	Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
GB0707706D0 (en) *	2007-04-20	2007-05-30	Glaxo Group Ltd	Compounds
DK2137196T3 (da)	2007-04-20	2011-01-10	Glaxo Group Ltd	Tricykliske nitrogenholdige forbindelser som antibakterielle midler
EP2005995A1 (fr) *	2007-06-22	2008-12-24	Glaxo Group Limited	Composés hétérocycliques pour le traitement de la tuberculose
EP2080761A1 (fr)	2008-01-18	2009-07-22	Glaxo Group Limited	Composés
RU2010138648A (ru)	2008-02-20	2012-03-27	Актелион Фармасьютиклз Лтд (Ch)	Азатрициклические соединения антибиотиков
TW200944529A (en)	2008-04-15	2009-11-01	Actelion Pharmaceuticals Ltd	Tricyclic antibiotics
RU2011108008A (ru)	2008-08-04	2012-09-10	Актелион Фармасьютиклз Лтд (Ch)	Производные трициклического алкиламинометилоксазолидинона
MY158520A (en)	2008-10-07	2016-10-14	Actelion Pharmaceuticals Ltd	Tricyclic oxazolidinone antibiotic compounds
US20110275661A1 (en)	2008-10-17	2011-11-10	Glaxo Group Limited	Tricyclic nitrogen compounds used as antibacterials
BRPI0924081A2 (pt)	2008-12-12	2018-03-20	Actelion Pharmaceuticals Ltd	DERIVADOS DE 5- AMINO -2-(1-hIDROXI-ETIL)- TETRAHIDROPIRANO.
ES2561631T3 (es)	2009-01-15	2016-02-29	Glaxo Group Limited	Compuestos de naftiridin-2(1H)-ona útiles como agentes antibacterianos
TW201313726A (zh)	2011-09-16	2013-04-01	Actelion Pharmaceuticals Ltd	製造合成之中間體之方法
US9029368B2 (en)	2011-11-30	2015-05-12	Actelion Pharmaceuticals Ltd.	3,7-disubstituted octahydro-2H-pyrido[4,3-E][1,3]oxazin-2-one antibiotics
WO2016027249A1 (fr)	2014-08-22	2016-02-25	Glaxosmithkline Intellectual Property Development Limited	Composés contenant de l'azote tricyclique pour le traitement de l'infection à neisseria gonorrhoeae
EP3590341A4 (fr)	2017-02-28	2021-03-10	Mitsui Chemicals Agro, Inc.	Composition de prévention de maladies des plantes et procédé de prévention de maladies des plantes l'utilisant
WO2018207023A2 (fr) *	2017-05-10	2018-11-15	Albajuna Therapeutics, S.L.	Dérivés de protéine de fusion fc présentant une double activité élevée immunomodulatrice et antivirale contre le vih
JP2023506147A (ja)	2019-12-02	2023-02-15	ストーム・セラピューティクス・リミテッド	Ｍｅｔｔｌ３阻害剤としてのポリヘテロ環式化合物
SMT202400488T1 (it)	2019-12-06	2025-01-14	Vertex Pharma	Tetraidrofurani sostituiti come modulatori dei canali del sodio

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3323868A (en) *	1961-12-14	1967-06-06	Laporte Chemical	Manufacture of hydrogen peroxide
NL294427A (fr) *	1962-06-23
GB1394373A (en) *	1972-05-17	1975-05-14	Pfizer Ltd	Control of plant diseases
US4066706A (en) *	1975-04-21	1978-01-03	Halcon International, Inc.	Preparation of ethylbenzene hydroperoxide
DE2805915C3 (de) *	1978-02-13	1981-11-05	Dynamit Nobel Ag, 5210 Troisdorf	Reaktor zur Oxidation von Gemischen aus p-Xylol und p-Toluylsäuremethylester mit sauerstoffhaltigen Gasen in flüssiger Phase
DE2914218C2 (de) *	1978-04-12	1985-10-24	Otsuka Pharmaceutical Co. Ltd., Tokio/Tokyo	N-Acylderivate des Ampicillins und Amoxicillins, Verfahren zu deren Herstellung und pharmazeutische Zubereitungen, welche die Verbindungen enthalten
US4416884A (en) *	1978-04-12	1983-11-22	Otsuka Pharmaceutical Co., Ltd.	Piperazinylbenzoheterocyclic compounds
NO156828C (no) *	1980-11-10	1987-12-02	Otsuka Pharma Co Ltd	Analogifremgangsm te for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser.
ATE21514T1 (de) *	1982-03-25	1986-09-15	Ciba Geigy Ag	Verfahren zur herstellung von 1,2,5,6-tetrahydro4h-pyrrolo(3,2,1-ij)-chinolin-4-on und neue 5ch820325
US4595755A (en) *	1982-03-25	1986-06-17	Ciba-Geigy Corporation	5-halo-1,2,3-(1,2-dihydropyrrolo)-4-quinolones
US4603199A (en) *	1982-10-25	1986-07-29	Riker Laboratories, Inc.	Phenyl-substituted tricyclic antibacterial agent intermediates
US4443447A (en) *	1982-10-25	1984-04-17	Riker Laboratories, Inc.	Phenyl-substituted tricyclic antibacterial agents
US6121285A (en) *	1995-11-22	2000-09-19	Daiichi Pharmaceutical Co., Ltd.	Substituted aminocycloalkylpyrrolidine derivatives and cis-substituted aminocycloalkylpyrrolidine derivatives
GB9622386D0 (en) *	1996-10-28	1997-01-08	Sandoz Ltd	Organic compounds
JPH11222407A (ja) *	1997-11-14	1999-08-17	Sankyo Co Ltd	新規殺菌剤
US7825121B2 (en) *	1999-05-04	2010-11-02	Schering Corporation	Piperazine derivatives useful as CCR5 antagonists
US6289745B1 (en) *	1999-05-04	2001-09-18	James Bowers	High temperature insertion type flow element and mounting extension
US6391865B1 (en) *	1999-05-04	2002-05-21	Schering Corporation	Piperazine derivatives useful as CCR5 antagonists
US6689765B2 (en) *	1999-05-04	2004-02-10	Schering Corporation	Piperazine derivatives useful as CCR5 antagonists
GB0101577D0 (en) *	2001-01-22	2001-03-07	Smithkline Beecham Plc	Compounds
UY27192A1 (es) *	2001-03-01	2002-09-30	Smithkline Beecham Corp	Inhibidores de peptido-deformilasa
GB0112836D0 (en) *	2001-05-25	2001-07-18	Smithkline Beecham Plc	Medicaments
US7109213B2 (en) *	2002-01-29	2006-09-19	Glaxo Group Limited	Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
AR040336A1 (es) *	2002-06-26	2005-03-30	Glaxo Group Ltd	Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
PA8577501A1 (es) *	2002-07-25	2004-02-07	Warner Lambert Co	Inhibidores de quinasas
TW200427688A (en) *	2002-12-18	2004-12-16	Glaxo Group Ltd	Antibacterial agents
PT1675852E (pt) *	2003-09-22	2009-03-25	Janssen Pharmaceutica Nv	Quinolonas e naftiridonas heterocíclicas de 7-aminoalquilidenilo
US7691850B2 (en) *	2004-06-15	2010-04-06	Glaxo Group Limited	Antibacterial agents
EP1773831A1 (fr) *	2004-07-08	2007-04-18	Glaxo Group Limited	Agents antibacteriens
US7732612B2 (en) *	2004-09-09	2010-06-08	Janssen Pharmaceutica, N.V.	7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
MY150958A (en) *	2005-06-16	2014-03-31	Astrazeneca Ab	Compounds for the treatment of multi-drug resistant bacterial infections
EP1900732A4 (fr) *	2005-06-24	2009-11-18	Toyama Chemical Co Ltd	Nouveau composé hétérocyclique azoté et sel de celui-ci
GB0521563D0 (en) *	2005-10-21	2005-11-30	Glaxo Group Ltd	Novel compounds
DE102005050892A1 (de) *	2005-10-21	2007-04-26	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DK1954697T3 (da) *	2005-10-21	2010-06-14	Glaxo Group Ltd	Peri-kondenserede tricykliske forbindelser, der er anvendelige som antibakterielle midler
EP1963324B1 (fr) *	2005-12-22	2010-04-21	Glaxo Group Limited	Composes heterocycliques, leur synthese et leur utilisation en tant qu'antibacteriens
ATE481406T1 (de) *	2006-04-06	2010-10-15	Glaxo Group Ltd	Pyrrolochinoxalinonderivate als antibakterielle mittel
GB0608263D0 (en) *	2006-04-26	2006-06-07	Glaxo Group Ltd	Compounds
SG164384A1 (en) *	2006-05-26	2010-09-29	Toyama Chemical Co Ltd	Novel heterocyclic compound or salt thereof and intermediate thereof
GB0613208D0 (en) *	2006-07-03	2006-08-09	Glaxo Group Ltd	Compounds
EP1992628A1 (fr) *	2007-05-18	2008-11-19	Glaxo Group Limited	Dérivés et analogues de N-éthylquinolones et N-éthylazaquinolones
GB0705672D0 (en) *	2007-03-23	2007-05-02	Glaxo Group Ltd	Compounds
EP1980251A1 (fr) *	2007-04-13	2008-10-15	Glaxo Group Limited	Derivées de pyrrolo[3,2,1-ij]quinoline-4-one pour traiter la tuberculose
GB0707708D0 (en) *	2007-04-20	2007-05-30	Glaxo Group Ltd	Compounds
GB0707706D0 (en) *	2007-04-20	2007-05-30	Glaxo Group Ltd	Compounds
DK2137196T3 (da) *	2007-04-20	2011-01-10	Glaxo Group Ltd	Tricykliske nitrogenholdige forbindelser som antibakterielle midler

2006
- 2006-10-17 DK DK06849235.4T patent/DK1954697T3/da active
- 2006-10-17 AT AT06849235T patent/ATE458737T1/de active
- 2006-10-17 ES ES06849235T patent/ES2340531T3/es active Active
- 2006-10-17 DE DE602006012535T patent/DE602006012535D1/de active Active
- 2006-10-17 NZ NZ567315A patent/NZ567315A/en unknown
- 2006-10-17 WO PCT/US2006/060023 patent/WO2007081597A2/fr active Application Filing
- 2006-10-17 EA EA200801128A patent/EA200801128A1/xx unknown
- 2006-10-17 AU AU2006335042A patent/AU2006335042A1/en not_active Abandoned
- 2006-10-17 CA CA002626641A patent/CA2626641A1/fr not_active Abandoned
- 2006-10-17 US US11/550,005 patent/US20080221110A1/en not_active Abandoned
- 2006-10-17 JP JP2008536625A patent/JP2009512695A/ja active Pending
- 2006-10-17 BR BRPI0617467-1A patent/BRPI0617467A2/pt not_active IP Right Cessation
- 2006-10-17 PT PT06849235T patent/PT1954697E/pt unknown
- 2006-10-17 KR KR1020087012082A patent/KR20080064173A/ko not_active Application Discontinuation
- 2006-10-17 PL PL06849235T patent/PL1954697T3/pl unknown
- 2006-10-17 SI SI200630624T patent/SI1954697T1/sl unknown
- 2006-10-17 US US12/090,947 patent/US20080280892A1/en not_active Abandoned
- 2006-10-17 EP EP06849235A patent/EP1954697B1/fr active Active
- 2006-10-19 TW TW095138495A patent/TW200736263A/zh unknown
- 2006-10-19 PE PE2006001266A patent/PE20070793A1/es not_active Application Discontinuation
- 2006-10-19 AR ARP060104571A patent/AR057981A1/es not_active Application Discontinuation
2008
- 2008-04-10 IL IL190803A patent/IL190803A0/en unknown
- 2008-04-15 MA MA30851A patent/MA29873B1/fr unknown
- 2008-04-25 CR CR9930A patent/CR9930A/es not_active Application Discontinuation
- 2008-05-13 NO NO20082191A patent/NO20082191L/no not_active Application Discontinuation
- 2008-09-10 HK HK08110046.5A patent/HK1118546A1/xx not_active IP Right Cessation
2010
- 2010-04-07 HR HR20100194T patent/HRP20100194T8/xx unknown
- 2010-05-10 CY CY20101100405T patent/CY1110137T1/el unknown

Also Published As

Publication number	Publication date
PT1954697E (pt)	2010-05-17
MA29873B1 (fr)	2008-10-03
ATE458737T1 (de)	2010-03-15
DK1954697T3 (da)	2010-06-14
IL190803A0 (en)	2008-12-29
DE602006012535D1 (de)	2010-04-08
JP2009512695A (ja)	2009-03-26
EP1954697B1 (fr)	2010-02-24
AR057981A1 (es)	2008-01-09
SI1954697T1 (sl)	2010-05-31
CA2626641A1 (fr)	2007-07-19
HK1118546A1 (en)	2009-02-13
ES2340531T3 (es)	2010-06-04
EA200801128A1 (ru)	2008-10-30
PL1954697T3 (pl)	2010-07-30
US20080280892A1 (en)	2008-11-13
PE20070793A1 (es)	2007-08-23
TW200736263A (en)	2007-10-01
NZ567315A (en)	2011-01-28
WO2007081597A2 (fr)	2007-07-19
NO20082191L (no)	2008-07-16
KR20080064173A (ko)	2008-07-08
CY1110137T1 (el)	2015-01-14
AU2006335042A1 (en)	2007-07-19
HRP20100194T1 (hr)	2010-05-31
US20080221110A1 (en)	2008-09-11
WO2007081597A3 (fr)	2008-06-12
HRP20100194T8 (en)	2010-06-30
BRPI0617467A2 (pt)	2011-07-26
EP1954697A2 (fr)	2008-08-13

Publication	Publication Date	Title
CR9930A (es)	2008-07-29	Compuestos
CR20150586A (es)	2016-04-04	Compuestos triciclicos que contienen nitrogeno como agentes antibactercianos
TW200801001A (en)	2008-01-01	Compounds
ATE486079T1 (de)	2010-11-15	Azatricyclische verbindungen und deren verwendung
HN2008000188A (es)	2010-11-09	7- aza- indazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y su utilizacion
CR11548A (es)	2010-08-13	Azolilmetiloxiranos, su uso y agentes que los contienen
SG173374A1 (en)	2011-08-29	Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
PA8836801A1 (es)	2010-05-26	Polipeptidos g-csf de bovino modificados y sus usos
PA8667201A1 (es)	2006-10-13	Nuevos compuestos farmaceuticos
EA201270308A1 (ru)	2013-01-30	Конъюгаты димеров пирроло [1,4]бензодиазепина в качестве противоракового средства
CL2007000311A1 (es)	2008-01-25	Compuestos derivados de cromen-2-ona; composicion farmaceutica que los comprende;y su uso en el trastamiento de un trastorno proliferativos como es el cancer.
CR9786A (es)	2008-05-22	Compuestos de bencimidazol-tiofeno
TW200715634A (en)	2007-04-16	Stable organic devices
CL2007002182S1 (es)	2008-01-11	Terminal.
CR9223A (es)	2007-11-23	18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen
PA8604401A1 (es)	2004-12-16	Productos aril-heteroaromaticos, composiciones que los contienen y su utilizacion.
CR10548A (es)	2009-01-27	18-metil-19nor-androst-4-en-17, 17-espiroeteres (18-metil-19-nor-20-espirox-4-en-3-onas) asi como preparaciones farmaceuticas que los contienen
HN2009000856A (es)	2011-10-19	Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
CR8300S (es)	2008-10-29	Recipiente para ajo
CR20150080A (es)	2015-04-06	Derivados y analogos de n-etilquinolonas y n-etilazaquinolonas
ES2422173T3 (es)	2013-09-09	Composiciones que contienen aecuorina y procedimientos de uso de las mismas
UY30570A1 (es)	2008-05-02	Derivaods de feniloxianilina
CL2012001759A1 (es)	2012-12-07	Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica.
PA8795401A1 (es)	2009-04-23	Asociacion entre un antiaterotrombotico y un inhibidor de la enzima de conversion de la angiotensina
GT200500165A (es)	2006-03-02	Metabolitos de indolilalquilamina como ligandos de 5-hidroxitriptamina-6

Legal Events

Date	Code	Title	Description
2013-04-05	FA	Abandonment or withdrawal (granting procedure)